Nina Vahl

2.0k total citations
43 papers, 1.7k citations indexed

About

Nina Vahl is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nina Vahl has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Physiology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nina Vahl's work include Growth Hormone and Insulin-like Growth Factors (40 papers), Diet and metabolism studies (14 papers) and Lipid metabolism and disorders (12 papers). Nina Vahl is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (40 papers), Diet and metabolism studies (14 papers) and Lipid metabolism and disorders (12 papers). Nina Vahl collaborates with scholars based in Denmark, United States and Australia. Nina Vahl's co-authors include Jens Otto Lunde Jørgensen, Jens Sandahl Christiansen, Claus Hagen, Hans Ørskov, Sanne Fisker, J. S. Christiansen, Anders Juul, Torben Bæk Hansen, Anne Grethe Jurik and Tony Bill Hansen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and International Journal of Obesity.

In The Last Decade

Nina Vahl

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina Vahl Denmark	25	1.4k	586	342	315	278	43	1.7k
K. Ho Australia	11	1.2k 0.9×	449 0.8×	161 0.5×	274 0.9×	198 0.7×	17	1.6k
G.J. Blok Netherlands	11	1.4k 1.0×	477 0.8×	391 1.1×	250 0.8×	312 1.1×	14	1.6k
J. Bellone Italy	24	1.4k 1.0×	463 0.8×	205 0.6×	446 1.4×	488 1.8×	66	2.0k
P M Martha United States	21	1.1k 0.8×	255 0.4×	173 0.5×	382 1.2×	282 1.0×	41	1.5k
Margareta Bramnert Sweden	19	889 0.6×	331 0.6×	309 0.9×	203 0.6×	168 0.6×	38	1.2k
Andrew Toogood United Kingdom	30	2.3k 1.7×	465 0.8×	371 1.1×	419 1.3×	394 1.4×	59	2.8k
P. S. Sharp United Kingdom	19	1.0k 0.7×	313 0.5×	381 1.1×	263 0.8×	188 0.7×	30	1.7k
Andrew J. Weissberger Australia	17	1.1k 0.8×	283 0.5×	147 0.4×	288 0.9×	283 1.0×	22	1.3k
Howard B. A. Baum United States	11	838 0.6×	292 0.5×	159 0.5×	206 0.7×	194 0.7×	20	1.2k
Suzan S. Pezzoli United States	24	1.3k 1.0×	889 1.5×	133 0.4×	245 0.8×	230 0.8×	32	2.1k

Countries citing papers authored by Nina Vahl

Since Specialization

Citations

This map shows the geographic impact of Nina Vahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Vahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Vahl more than expected).

Fields of papers citing papers by Nina Vahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Vahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Vahl. The network helps show where Nina Vahl may publish in the future.

Co-authorship network of co-authors of Nina Vahl

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Vahl. A scholar is included among the top collaborators of Nina Vahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Vahl. Nina Vahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Christiansen, Jens Sandahl, Nina Vahl, Helene Nørrelund, & Jens Otto Lunde Jørgensen. (2002). Effects of GH replacement in young patients with childhood onset GH deficiency.. PubMed. 32–6. 2 indexed citations

Abrahamsen, Bo, J. Hangaard, Torben Bæk Hansen, et al.. (2002). Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult‐onset GH deficiency: results from two 12‐month randomized studies. Clinical Endocrinology. 57(2). 273–281. 20 indexed citations

Vahl, Nina. (2000). Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 85(5). 1874–1881. 39 indexed citations

Nørrelund, Helene, Nina Vahl, Anders Juul, et al.. (2000). Continuation of Growth Hormone (GH) Therapy in GH-Deficient Patients during Transition from Childhood to Adulthood: Impact on Insulin Sensitivity and Substrate Metabolism. The Journal of Clinical Endocrinology & Metabolism. 85(5). 1912–1917. 58 indexed citations

Nørrelund, Helene, Sanne Fisker, Nina Vahl, et al.. (1999). Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults. Growth Hormone & IGF Research. 9(1). 52–60. 37 indexed citations

Fisker, Sanne, Jens Otto Lunde Jørgensen, Nina Vahl, Hans Ørskov, & JS Christiansen. (1999). Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults. European Journal of Endocrinology. 141(6). 601–608. 43 indexed citations

Jørgensen, Jens Otto Lunde, Nina Vahl, Rolf Dall, & Jens Sandahl Christiansen. (1998). Resting metabolic rate in healthy adults: Relation to growth hormone status and leptin levels. Metabolism. 47(9). 1134–1139. 41 indexed citations

Jørgensen, Jens Otto Lunde, Nina Vahl, Tony Bill Hansen, et al.. (1998). Determinants of serum insulin‐like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clinical Endocrinology. 48(4). 479–486. 53 indexed citations

Vahl, Nina, et al.. (1998). The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study. International Journal of Obesity. 22(6). 529–536. 43 indexed citations

10.

Vahl, Nina, Niels Møller, Torsten Lauritzen, Jens Sandahl Christiansen, & Jens Otto Lunde Jørgensen. (1997). Metabolic Effects and Pharmacokinetics of a Growth Hormone Pulse in Healthy Adults: Relation to Age, Sex, and Body Composition. The Journal of Clinical Endocrinology & Metabolism. 82(11). 3612–3618. 69 indexed citations

11.

Vahl, Nina, et al.. (1997). Somatopause and Adiposity. Hormone Research. 48(5). 101–104. 18 indexed citations

12.

Vahl, Nina, Jens Otto Lunde Jørgensen, Casper Skjærbæk, et al.. (1997). Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. American Journal of Physiology-Endocrinology and Metabolism. 272(6). E1108–E1116. 153 indexed citations

13.

Fisker, Sanne, Nina Vahl, Torben Bæk Hansen, et al.. (1997). Serum leptin is increased in growth hormone—deficient adults: Relation to body composition and effects of placebo-controlled growth hormone therapy for 1 year. Metabolism. 46(7). 812–817. 70 indexed citations

14.

Hansen, Torben Bæk, Nina Vahl, Jens Otto Lunde Jørgensen, J. S. Christiansen, & Clinton E. Hagen. (1997). [Soft tissue changes in adults with acquired growth hormone deficiency during substitution treatment. A double-blind, randomized, placebo-controlled study after a year of treatment].. PubMed. 159(28). 4394–9. 1 indexed citations

15.

Fisker, Sanne, Nina Vahl, Jens Otto Lunde Jørgensen, Jens Sandahl Christiansen, & Hans Ørskov. (1997). Abdominal Fat Determines Growth Hormone-Binding Protein Levels in Healthy Nonobese Adults¹. The Journal of Clinical Endocrinology & Metabolism. 82(1). 123–128. 45 indexed citations

16.

Jørgensen, Jens Otto Lunde, Nina Vahl, Tony Bill Hansen, et al.. (1996). Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition. Clinical Endocrinology. 45(6). 681–688. 110 indexed citations

17.

Hansen, Torben Bæk, Kim Brixen, Nina Vahl, et al.. (1996). Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.. The Journal of Clinical Endocrinology & Metabolism. 81(9). 3352–3359. 107 indexed citations

18.

Vahl, Nina, Michael Højby Rasmussen, Jens Otto Lunde Jørgensen, et al.. (1996). Bioavailability of Recombinant Human Growth Hormone in Different Concentrations and Formulations. Pharmacology & Toxicology. 79(3). 144–149. 6 indexed citations

19.

Hansen, Torben Bæk, et al.. (1995). Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double‐blind, randomized, placebo‐controlled study. Clinical Endocrinology. 43(6). 689–696. 40 indexed citations

20.

Wolthers, Troels, et al.. (1994). Adult Growth Hormone Deficiency. PubMed. 42(4-5). 235–241. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact